CVS Health Corporation $CVS Shares Sold by Trust Co. of Vermont

Trust Co. of Vermont trimmed its position in CVS Health Corporation (NYSE:CVS) by 16.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 34,151 shares of the pharmacy operator’s stock after selling 6,671 shares during the quarter. Trust Co. of Vermont’s holdings in CVS Health were worth $2,575,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the business. Avion Wealth raised its stake in shares of CVS Health by 99.0% in the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after purchasing an additional 189 shares in the last quarter. Harbor Asset Planning Inc. bought a new position in shares of CVS Health in the second quarter valued at about $30,000. Bell Investment Advisors Inc lifted its holdings in shares of CVS Health by 119.8% during the first quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock worth $31,000 after buying an additional 248 shares in the last quarter. Front Row Advisors LLC grew its position in CVS Health by 436.5% during the second quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock worth $31,000 after buying an additional 371 shares in the last quarter. Finally, Roxbury Financial LLC grew its stake in CVS Health by 78.3% during the second quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock worth $32,000 after buying an additional 202 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Trading Up 0.8%

Shares of CVS opened at $78.37 on Tuesday. The company has a current ratio of 0.83, a quick ratio of 0.63 and a debt-to-equity ratio of 0.83. CVS Health Corporation has a 1-year low of $43.56 and a 1-year high of $85.15. The firm has a market capitalization of $99.49 billion, a price-to-earnings ratio of 206.24, a PEG ratio of 0.77 and a beta of 0.48. The firm’s 50-day moving average price is $79.09 and its 200-day moving average price is $72.60.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.24. The company had revenue of $102.87 billion for the quarter, compared to the consensus estimate of $98.85 billion. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The firm’s quarterly revenue was up 7.8% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.09 EPS. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Sell-side analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current year.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the company. Royal Bank Of Canada reissued an “outperform” rating on shares of CVS Health in a research note on Thursday, December 4th. Morgan Stanley raised their target price on CVS Health from $89.00 to $93.00 and gave the company an “overweight” rating in a report on Wednesday, December 10th. JPMorgan Chase & Co. lifted their target price on CVS Health from $93.00 to $101.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 17th. Wall Street Zen lowered shares of CVS Health from a “buy” rating to a “hold” rating in a research report on Saturday, November 1st. Finally, TD Cowen raised their price objective on shares of CVS Health from $100.00 to $105.00 and gave the company a “buy” rating in a research report on Wednesday, December 10th. Two investment analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $94.67.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.